These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29567587)

  • 1. Clinical and laboratory characteristics of isolated lupus anticoagulants.
    Mattia E; Tonello M; Del Ross T; Zerbinati P; Campello E; Simioni P; Ruffatti A
    Thromb Res; 2018 May; 165():51-53. PubMed ID: 29567587
    [No Abstract]   [Full Text] [Related]  

  • 2. The activated seven lupus anticoagulant assay detects clinically significant antibodies.
    Moore GW; Rangarajan S; Savidge GF
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):332-7. PubMed ID: 17895508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulation tests and anti-phospholipid antibodies in patients positive for lupus anticoagulant.
    Sakakura M; Wada H; Watanabe R; Mamamuro M; Okugawa Y; Nakasaki T; Nakase T; Wakita Y; Minamikawa K; Mori Y; Nshikawa M; Shiku H
    Clin Appl Thromb Hemost; 2000 Jul; 6(3):144-50. PubMed ID: 10898274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative assays to dRVVT and aPTT for lupus anticoagulant detection.
    Moore GW
    Am J Hematol; 2020 Aug; 95(8):992-998. PubMed ID: 32311119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four coagulation tests to detect plasma lupus anticoagulants.
    Saxena R; Saraya AK; Kotte VK; Singh YN; Prasad L; Malviya AN
    Am J Clin Pathol; 1991 Dec; 96(6):755-8. PubMed ID: 1746492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lupus Anticoagulant Testing: Activated Partial Thromboplastin Time (APTT) and Silica Clotting Time (SCT).
    Tripodi A; Chantarangkul V
    Methods Mol Biol; 2017; 1646():177-183. PubMed ID: 28804829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lupus anticoagulants: pathogenesis and laboratory diagnosis.
    Court EL
    Br J Biomed Sci; 1997 Dec; 54(4):287-98. PubMed ID: 9624740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests.
    Zhang L; Whitis JG; Embry MB; Hollensead SC
    Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coagulation assays for the lupus anticoagulant: review and critique of current methodology.
    Triplett DA
    Stroke; 1992 Feb; 23(2 Suppl):I11-4. PubMed ID: 1561667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Avoiding errors in the laboratory evaluation of potent lupus anticoagulants.
    Penmetsa GK; Rodgers GM; Smock KJ
    Am J Hematol; 2010 Apr; 85(4):272-4. PubMed ID: 20196174
    [No Abstract]   [Full Text] [Related]  

  • 13. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of mixing test-specific cut-off in lupus anticoagulant mixing test interpretation for multiple reagents.
    Kumano O; Moore GW
    Thromb Res; 2023 Nov; 231():39-43. PubMed ID: 37801773
    [No Abstract]   [Full Text] [Related]  

  • 15. Diluted Russell's viper venom time and colloidal silica clotting time for the identification of the phospholipid-dependent inhibitors of coagulation.
    Norbis F; Barbui T; Galli M
    Thromb Res; 1997 Mar; 85(5):427-31. PubMed ID: 9076899
    [No Abstract]   [Full Text] [Related]  

  • 16. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An evaluation of two commercial test procedures for the detection of lupus anticoagulant.
    Schjetlein R; Wisløff F
    Am J Clin Pathol; 1995 Jan; 103(1):108-11. PubMed ID: 7817935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent development of lupus anticoagulants in critically ill patients treated under intensive care conditions.
    Wenzel C; Stoiser B; Locker GJ; Laczika K; Quehenberger P; Kapiotis S; Frass M; Pabinger I; Knöbl P
    Crit Care Med; 2002 Apr; 30(4):763-70. PubMed ID: 11940742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
    Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
    Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. As compared to kaolin clotting time, silica clotting time is a specific and sensitive automated method for detecting lupus anticoagulant.
    Dragoni F; Minotti C; Palumbo G; Faillace F; Redi R; Bongarzoni V; Avvisati G
    Thromb Res; 2001 Jan; 101(2):45-51. PubMed ID: 11342205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.